The use of corticosteroids to treat keloids: A review

International Journal of Lower Extremity Wounds

Volumn 7, Issue 3, 2008, Pages 137-145

  Roques, Claude ^a   Téot, Luc ^b  

^a Pediatric Rehabilitation Centre   (France)

^b LAPEYRONIE HOSPITAL   (France)

Author keywords

Corticosteroids; Hypertrophic scars; Keloid; Triamcinolone acetonide

Indexed keywords

ALPHA2B INTERFERON; BASIC FIBROBLAST GROWTH FACTOR; CONTRACTUBEX; CORTICOSTEROID; ETANERCEPT; FLUOROURACIL; GROWTH FACTOR; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1; TRIAMCINOLONE ACETONIDE; VASCULOTROPIN;

COLLAGEN METABOLISM; CORTICOSTEROID THERAPY; CRYOTHERAPY; CUSHINGOID SYNDROME; DRUG EFFICACY; DRUG SAFETY; FEVER; FLU LIKE SYNDROME; HUMAN; HYPOPIGMENTATION; INJECTION SITE INFLAMMATION; KELOID; LIPOATROPHY; MECHANICAL STIMULATION; PAIN; PRIORITY JOURNAL; PRURITUS; PULSED DYE LASER; REVIEW; SCAR; SKIN ATROPHY; SKIN FIBROBLAST; SUBCUTANEOUS FAT DISORDER; TELANGIECTASIA;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; CICATRIX, HYPERTROPHIC; COLLAGEN; FIBROBLAST GROWTH FACTOR 2; HUMANS; INSULIN-LIKE GROWTH FACTOR I; KELOID; TRANSFORMING GROWTH FACTOR BETA1; TRIAMCINOLONE ACETONIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 49749116096     PISSN: 15347346     EISSN: 15526941     Source Type: Journal    
DOI: 10.1177/1534734608320786     Document Type: Review

References (32)

1. Mustoe TA, Cooter RD, Gold MH,, et al. International Advisory Panel on Scar Management. International clinical recommendations on scar management. Plast Reconstr Surg. 2002 ; 110: 560-571.
2. Köse O., Waseem A. Keloids and hypertrophic scars: are they two different sides of the same coin ? Dermatol Surg. 2008 ; 34: 336-346.
3. Niessen FB, Spauwen P., Schalkwijk J., Kon M. On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg. 1999 ; 104: 1435-1458.
4. Carroll LA, Hanasono MM, Mikulec AA, Kita M., Koch RJ Triamcinolone stimulates bFGF production and inhibits TGF-beta1 production by human dermal fibroblasts. Dermatol Surg. 2002 ; 28: 704-709.
5. Boyce DE, Ciampolini J., Ruge F., Murison MS, Harding KG Inflammatory-cell subpopulations in keloid scars. Br J Plast Surg. 2001 ; 54: 511-516.
6. Kim A., DiCarlo J., Cohen C., et al. Are keloids really "gliloids"? High-level expression of gli-1 oncogene in keloids. J Am Acad Dermatol. 2001 ; 45: 707-711.
7. Ishihara H., Yoshimoto H., Fujioka M., et al. Keloid fibroblasts resist ceramide-induced apoptosis by over expression of insulin-like growth factor I receptor. J Invest Dermatol. 2000 ; 115: 1065-1071.
8. Gira A., Brown L., Washington C., Cohen C., Arbiser JL Keloids demonstrate high-level epidermal expression of vascular endothelial growth factor. J Am Acad Dermatol. 2004 ; 50: 850-853.
9. Wu WS, Wang FS, Yang K D., Huang CC, Kuo YR Dexamethasone induction of keloid regression through effective suppression of VEGF expression and keloid fibroblast proliferation. J Invest Dermatol. 2006 ; 126: 1264-1271.
10. Rahban S., Garner W. Fibroproliferative scars. Clin Plast Surg. 2003 ; 30: 77-89.
11. Darzi MA, Chowdri NA, Kaul SK, Khan M. Evaluation of various methods of treating keloids and hypertrophic scars: a 10-year follow-up study. Br J Plast Surg. 1992 ; 45: 374-379.
12. Robles D., Moore E., Draznin M., Berg D. Keloids: pathophysiology and management. Dermatol Online J. 2007 ; 13: 9.
13. Atiyeh BS Nonsurgical management of hypertrophic scars: evidence-based therapies, standard practices, and emerging methods. Aesthetic Plast Surg. 2007 ; 31: 468-492.
14. Muneuchi G., Suzuki S., Onodera M., Ito O., Hata Y., Igawa HH Long-term outcome of intralesional injection of triamcinolone acetonide for the treatment of keloid scars in Asian patients. Scand J Plast Reconstr Surg Hand Surg. 2006 ; 40: 111-116.
15. Ritota PC, Lo AK Cushing's syndrome in postburn children following intralesional triamcinolone injection. Ann Plast Surg. 1996 ; 36: 508-511.
16. Kauh YC, Rouda S., Mondragon G., et al. Major suppression of pro-α1(I) type I collagen gene expression in the dermis after keloid excision and immediate intrawound injection of triamcinolone acetonide. J Am Acad Dermatol. 1997 ; 37: 586-589.
17. Donkor P. Head and neck keloid: treatment by core excision and delayed intralesional injection of steroid. J Oral Maxillofac Surg. 2007 ; 65: 1292-1296.
18. Davison S., Mess S., Kauffman LC, Al- Attar A. Ineffective treatment of keloids with interferon alpha-2b. Plast Reconstr Surg. 2006 ; 117: 247-252.
19. Shaffer J., Taylor S., Cook-Bolden F. Keloidal scars: a review with a critical look at therapeutic options. J Am Acad Dermatol. 2002 ; 46: S63 - S96.
20. Hirshowitz B., Lerner D., Moscona AR Treatment of keloid scars by combined cryosurgery and intralesional corticosteroids. Aesthetic Plast Surg. 1982 ; 6: 153-158.
21. Ceilley RI, Babin RW The combined use of cryosurgery and intralesional injections of suspensions of fluorinated adrenocorticosteroids for reducing keloids and hypertrophic scars. J Dermatol Surg Oncol. 1979 ; 5: 54-56.
22. Farahnaz FN, Jamshid N., Koroush A. Comparison of therapeutic response of keloids and hypertrophic scars to cryotherapy plus intralesional steroid and bleomycin tattoo. Indian J Dermatol. 2005 ; 50: 129-132.
23. Mutalik S. Treatment of keloids and hypertrophic scars. Indian J Dermatol Venereol Leprol. 2005 ; 71: 3-8.
24. Boutli-Kasapidou F., Tsakiri A., Anagnostou E., Mourellou O. Hypertrophic and keloidal scars: an approach to poly-therapy. Int J Dermatol. 2005 ; 44: 324-327.
25. Manuskiatti W., Fitzpatrick RE Treatment response of keloids and hypertrophic sternotomy scars. Arch Dermatol. 2002 ; 138: 1149-1155.
26. Alster T. Laser scar revision: comparison study of 585-nm pulsed dye laser with and without intralesional corticosteroids. Dermatol Surg. 2003 ; 29: 25-29.
27. Asilian A., Darougheh A., Shariati F. New combination of triamcinolone, 5-fluorouracil, and pulsed-dye laser for treatment of keloid and hypertrophic scars. Dermatol Surg. 2006 ; 32: 907-915.
28. Lee JH, Kim SE, Lee AY Effects of interferon-α2b on keloid treatment with triamcinolone acetonide intralesional injection. Int J Dermatol. 2008 ; 47: 183-186.
29. Berman B., Flores R. Recurrence rates of excised keloids treated with postoperative triamcinolone acetonide injections or interferon alfa-2b injections. J Am Acad Dermatol. 1997 ; 37: 755-757.
30. Berman B., Patel J., Perez O., Block S. A prospective, randomized, single-blind, comparative study evaluating the tolerability and efficacy of intralesional etanercept compared to intralesional triamcinolone acetonide for the treatment of keloids. J Am Acad Dermatol. 2008 ; 58 (2, suppl 2). AB34.
31. Beuth J., Hunzelmann N., Van Leendert R., Basten R., Noehle M., Schneider B. Safety and efficacy of local administration of Contractubex to hypertrophic scars in comparison to corticosteroid treatment. Results of a multicenter, comparative epidemiological cohort study in Germany. In Vivo. 2006 ; 20: 277-283.
32. Al-Attar A., Mess S., Thomassen JM, Kauffman CL, Davison SP Keloid pathogenesis and treatment. Plast Reconstr Surg. 2006 ; 117: 286-300.